In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to health ...

A common blood test may miss ovarian cancer in some racial groups Black and Native American women are more likely to get false negative results Experts say the test may need to be changed to help all ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...